Home
Search:
1146 feeds
357 categories
4484 articles (<24 hours)
20 registered users

Use the Mobile version
Mobile

Follow our Twitter feed

View our Linkpartners
Links

Username:
Password:

Register | Retrieve

General


Valid HTML 4.01 Transitional

RSS FeedsNew Novartis medicine AdakveoŽ (crizanlizumab) approved by FDA to reduce frequency of pain crises in individuals living with sickle cell disease
(WorldNews Belgium)

 
 

16 november 2019 01:01:06

 
New Novartis medicine AdakveoŽ (crizanlizumab) approved by FDA to reduce frequency of pain crises in individuals living with sickle cell disease
(WorldNews Belgium)
 




New Novartis medicine AdakveoŽ (crizanlizumab) approved by FDA to reduce frequency of pain crises in individuals living with sickle cell disease 15 Nov 2019 21:06 CET Company Name - ISN Market Symbol - New Novartis medicine AdakveoŽ (crizanlizumab) approved by FDA to reduce frequency of pain crises in individuals living with sickle cell disease Sickle cell pain crises are unpredictable, severe events associated with life-threatening complications1 Adakveo reduced the annual rate of sickle cell pain crises by 45% compared to placebo (1.63 vs 2.98) and the annual rate of days hospitalized (4 vs 6.87) in a 52-week study2 Approximately 100,000 people in the United States, most of whom are of...
 
32 viewsCategory: General > Europe > Belgium
 
Russia vs Belgium: Live stream, TV channel, kick-off time and team news for Euro 2020 qualifier
(WorldNews Belgium)
ASIT biotech: Additional Information: Declaration of Dissociation of a Member of the Board of Directors at the General Assembly
(WorldNews Belgium)
 
 
blog comments powered by Disqus


Copyright © 2008 - 2020 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Travel Photos Nachrichten Indigonet Finances Leer Mandarijn